Case Study: AprilBio secures a $448M licensing partnership and accelerates neuroimmune drug development with Donnelley Financial Solutions (DFIN) Venue Virtual Data Room

How Venue enabled a global licensing partnership to accelerate drug treatment development for neuroimmune diseases

AprilBio, a South Korean biopharmaceutical company founded in 2013 that develops specialized biologics and antibody drugs, needed to confidentially share proprietary preclinical and R&D data with prospective licensees for out-licensing due diligence. Because general-purpose file sharing was deemed too risky for sensitive materials, AprilBio engaged Donnelley Financial Solutions and its Venue Virtual Data Room to provide a purpose-built secure sharing solution.

Donnelley Financial Solutions implemented Venue with features such as automatic watermarks, user access expiration, multifactor authentication, audit trails and real-time reporting to control disclosures and streamline workflows. The secure, intuitive platform enabled AprilBio to complete a licensing partnership valued at US$448M, accelerating development of drug treatments for neuroimmune diseases while saving time through automated reporting and tightly controlled access.

AprilBio

Jamie Jaeheung Lee

Chief Development Officer